Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In the industry’s words – New Zealand’s MTANZ

This article was originally published in Clinica

Executive Summary

New Zealand’s healthcare system is undergoing reforms likely to impact on procurement policy. The Medical Technology Association of New Zealand (MTANZ), while recognising the need for efficiency, believes it is critical that innovation does not become a victim of the current drive to contain costs – not least because of the NZ medtech industry’s focus on the export market. Here, Angela Pantano, business development manager for MTANZ’s Emerging Medical Technologies Group details some of the initiatives underway to “help develop and grow this vital part of the economy”

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT095228

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel